rs61893682

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP5BP4BS2_Supporting

The NM_001040694.2(INCENP):​c.2415G>C​(p.Gln805His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.003 in 1,613,998 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (no stars).

Frequency

Genomes: 𝑓 0.0025 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 8 hom. )

Consequence

INCENP
NM_001040694.2 missense

Scores

5
13

Clinical Significance

Likely pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: -0.916

Publications

4 publications found
Variant links:
Genes affected
INCENP (HGNC:6058): (inner centromere protein) In mammalian cells, 2 broad groups of centromere-interacting proteins have been described: constitutively binding centromere proteins and 'passenger,' or transiently interacting, proteins (reviewed by Choo, 1997). The constitutive proteins include CENPA (centromere protein A; MIM 117139), CENPB (MIM 117140), CENPC1 (MIM 117141), and CENPD (MIM 117142). The term 'passenger proteins' encompasses a broad collection of proteins that localize to the centromere during specific stages of the cell cycle (Earnshaw and Mackay, 1994 [PubMed 8088460]). These include CENPE (MIM 117143); MCAK (MIM 604538); KID (MIM 603213); cytoplasmic dynein (e.g., MIM 600112); CliPs (e.g., MIM 179838); and CENPF/mitosin (MIM 600236). The inner centromere proteins (INCENPs) (Earnshaw and Cooke, 1991 [PubMed 1860899]), the initial members of the passenger protein group, display a broad localization along chromosomes in the early stages of mitosis but gradually become concentrated at centromeres as the cell cycle progresses into mid-metaphase. During telophase, the proteins are located within the midbody in the intercellular bridge, where they are discarded after cytokinesis (Cutts et al., 1999 [PubMed 10369859]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PP5
Variant 11-62150080-G-C is Pathogenic according to our data. Variant chr11-62150080-G-C is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 548641.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.010879815). . Strength limited to SUPPORTING due to the PP5.
BS2
High AC in GnomAd4 at 381 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INCENPNM_001040694.2 linkc.2415G>C p.Gln805His missense_variant Exon 18 of 19 ENST00000394818.8 NP_001035784.1 Q9NQS7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INCENPENST00000394818.8 linkc.2415G>C p.Gln805His missense_variant Exon 18 of 19 1 NM_001040694.2 ENSP00000378295.3 Q9NQS7-1
INCENPENST00000278849.5 linkc.2403G>C p.Gln801His missense_variant Exon 17 of 18 5 ENSP00000278849.4 Q9NQS7-2

Frequencies

GnomAD3 genomes
AF:
0.00250
AC:
381
AN:
152108
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0119
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00316
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00278
AC:
699
AN:
251344
AF XY:
0.00286
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0116
Gnomad NFE exome
AF:
0.00321
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00305
AC:
4454
AN:
1461772
Hom.:
8
Cov.:
31
AF XY:
0.00300
AC XY:
2185
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.000448
AC:
15
AN:
33480
American (AMR)
AF:
0.000157
AC:
7
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00174
AC:
150
AN:
86256
European-Finnish (FIN)
AF:
0.0114
AC:
608
AN:
53324
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.00320
AC:
3553
AN:
1111992
Other (OTH)
AF:
0.00179
AC:
108
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
235
471
706
942
1177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00250
AC:
381
AN:
152226
Hom.:
3
Cov.:
32
AF XY:
0.00289
AC XY:
215
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41536
American (AMR)
AF:
0.000327
AC:
5
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4820
European-Finnish (FIN)
AF:
0.0119
AC:
126
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00316
AC:
215
AN:
68002
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00262
Hom.:
0
Bravo
AF:
0.00164
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00372
AC:
32
ExAC
AF:
0.00278
AC:
337
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00191
EpiControl
AF:
0.00279

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Nephronophthisis Pathogenic:1
Dec 23, 2015
Yale Center for Mendelian Genomics, Yale University
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.36
T;.
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.40
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.85
D;T
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.7
M;.
PhyloP100
-0.92
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-2.2
N;N
REVEL
Benign
0.13
Sift
Uncertain
0.012
D;D
Sift4G
Benign
0.091
T;T
Polyphen
0.99
D;D
Vest4
0.37
MutPred
0.14
Gain of catalytic residue at Q805 (P = 0.076);.;
MVP
0.33
MPC
0.88
ClinPred
0.042
T
GERP RS
-3.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.33
Mutation Taster
=99/1
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61893682; hg19: chr11-61917552; COSMIC: COSV99074628; COSMIC: COSV99074628; API